Sign in

Global Hospital-Acquired Disease (HAD) Testing Market 2020: Enhancing Huge Growth and Latest Industry Trends by Top Players

Global Hospital-Acquired Disease (HAD) Testing Market 2020: Enhancing Huge Growth and Latest Industry Trends by Top Players

According to the latest report by IMARC Group titled, “Hospital Acquired Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the market was worth US$ 876 Million in 2018. Looking forward, IMARC expects the market to reach a value of US$ 2,190 Million by 2024, growing at a CAGR of around 16.5% during the next five years.

Hospital-acquired disease (HAD) testing involves the diagnosis of infections and medical ailments potentially caused by bacterial, viral and fungal pathogens. These ailments, including gastrointestinal, bloodstream and urinary tract infections (UTIs), are usually acquired from clinics, nursing homes, rehabilitation facilities or hospitals, when the outer layer of the skin comes in contact with pathogens which results in infections, especially after surgical operations. HAD testing commonly involves molecular diagnostics, urinalysis, immunoassay and physical examination of the infected area.

The global market is primarily driven by the increasing prevalence of HADs, especially in developing countries, owing to inadequate hygiene facilities available in the healthcare institutions. Furthermore, technological advancements and innovations in testing equipment, which facilitate efficient diagnosis, monitoring and prevention of HADs, are also contributing to the increasing adoption of testing devices across the globe. Other factors, including favorable government policies to improve healthcare infrastructure, along with an increasing number of research and development (R&D) activities in the healthcare sector, are projected to drive the market further.

Request for a sample copy of this report: https://www.imarcgroup.com/hospital-acquired-disease-testing-market/requestsample

Hospital Acquired Disease Testing Market Segmentation:

Market Breakup by Indication

1. UTI (Urinary Tract Infection)
2. SSI (Surgical Site Infection)
3. Pneumonia
4. Bloodstream Infections
5. MRSA (Methicillin-Resistant Staphylococcus Aureus)
6. Others

Market Breakup by Region

1. North America
2. Europe
3. Asia Pacific
4. Middle East and Africa
5. Latin America

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

USA: +1-631-791-1145
Email: [email protected]
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more